thiazoles has been researched along with Pleural Effusion in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.63) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (28.95) | 29.6817 |
2010's | 25 (65.79) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Adewunmi, CY; Alrubaye, RR; Del Rio Lopez, L; Fadel, CA | 1 |
Giannouli, A; Hatzitolios, AI; Kaiafa, G; Kakaletsis, N; Papadopoulos, N; Perifanis, V; Savopoulos, C; Zisekas, S | 1 |
Paydas, S | 1 |
Li, JY; Qiu, ZY; Xu, W | 1 |
Faiz, SA; Jimenez, CA; Sahay, S | 1 |
Ar, MC; Aydin, Y; Baslar, Z; Elverdi, T; Eskazan, AE; Eyice, D; Ferhanoglu, B; Kurt, EA; Ongoren Aydin, S; Ozbek, U; Salihoglu, A; Soysal, T; Tuzuner, N; Yalniz, FF | 1 |
Chang, H; Chou, WC; Hung, YS | 1 |
Amin, K; Dincer, HE; Podgaetz, E; Randall, N; Ustun, C | 1 |
Bergeron, A; Cony-Makhoul, P; Corm, S; Dubruille, V; Nicolini, FE; Rea, D; Rigal-Huguet, F | 1 |
Cortes, JE; Guilhot, F; Hughes, TP; Khoury, HJ; Kim, DW | 1 |
Snyder, DS | 1 |
Giles, FJ; Kelly, K; Mahalingam, D; Padmanabhan, S; Swords, R | 1 |
Doelken, P; Goldblatt, M; Gurung, P; Huggins, JT; Sahn, SA | 1 |
Gorospe, G; Masiello, D; Yang, AS | 1 |
Cortes, JE; Khoury, HJ; Matloub, Y; Paquette, RL; Porkka, K; Sinha, R | 1 |
Brigid Bradley-Garelik, M; Bullorsky, E; Charbonnier, A; Dombret, H; Ehninger, G; Larson, RA; Lilly, MB; Martinelli, G; Müller, MC; Ottmann, OG; Reiffers, JJ; Shah, NP; Zhu, C | 1 |
Akiyama, H; Fukuda, S; Kobayashi, T; Nagata, Y; Ohashi, K; Sakamaki, H; Yamashita, T | 1 |
Chen, J; Shen, J; Zheng, Z; Zhou, Y | 1 |
Brixey, AG; Light, RW | 1 |
Hatsumi, N; Hoshino, T; Miyawaki, K; Miyawaki, S; Sakura, T; Tahara, K; Takada, S | 1 |
Akiyama, H; Fukuda, S; Kamata, N; Nagata, Y; Ohashi, K; Sakamaki, H | 1 |
Alimena, G; Breccia, M | 1 |
Shayani, S | 1 |
Herndlhofer, S; Krauth, MT; Mitterbauer-Hohendanner, G; Schlögl, E; Schmook, MT; Valent, P | 1 |
Aydin, Y; Eskazan, AE; Ferhanoglu, B; Gulturk, E; Ongoren, S; Soysal, T | 1 |
Breccia, M; Isidori, A; Montefusco, E; Morra, E; Santini, V; Visani, G | 1 |
Castro, MJ; Jessurun, J; Pambuccian, SE | 1 |
Abruzzese, E; Alimena, G; Annunziata, M; Breccia, M; Castagnetti, F; Cavazzini, F; Fava, C; Gozzini, A; Latagliata, R; Luciano, L; Pane, F; Pregno, P; Rege-Cambrin, G; Rosti, G; Russo Rossi, A; Santini, V; Sica, S; Specchia, G; Stagno, F; Vigneri, P | 1 |
Hatake, K; Ito, Y; Miyazaki, M; Nakagawa, K; Okamoto, I; Seriu, T; Takahashi, S; Ueda, K | 1 |
Cho, BS; Goh, HG; Kim, D; Kim, DW; Kim, SH | 1 |
Valent, P | 1 |
Alimena, G; Annunziata, M; Breccia, M; Calistri, E; Capodanno, I; Castagnetti, F; Cavazzini, F; Crugnola, M; Fava, C; Ferrero, D; Gozzini, A; Gugliotta, G; Iurlo, A; Latagliata, R; Luciano, L; Musto, P; Stagno, F; Tiribelli, M; Vigneri, P; Visani, G | 1 |
Bramanti, S; Fabio, G; Fantini, NN; Greco, I; Lambertenghi-Deliliers, G; Radaelli, F | 1 |
Kathula, SK | 1 |
Countouriotis, A; Golenkov, A; Hamerschlak, N; Hellmann, A; Holowiecki, J; Hughes, T; Jootar, S; Kantarjian, H; Khoroshko, N; Masszi, T; Pasquini, R; Radich, J; Robak, T; Rousselot, P; Shah, N; Skotnicki, A; Zaritsky, A | 1 |
Bergeron, A; Bruzzoni-Giovanelli, H; Calvo, F; Levy, V; Meignin, V; Picard, C; Réa, D; Rousselot, P; Tamburini, J; Tazi, A | 1 |
Borthakur, G; Bruzzi, J; Cortes, J; Kantarjian, H; Munden, R; O'brien, S; Quintás-Cardama, A | 1 |
Hayashi, M; Oh, S; Yamaki, K | 1 |
10 review(s) available for thiazoles and Pleural Effusion
Article | Year |
---|---|
Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect?
Topics: Animals; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytosis; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Large granular lymphocytosis during dasatinib therapy.
Topics: Antineoplastic Agents; Clone Cells; Colitis; Dasatinib; Familial Primary Pulmonary Hypertension; Humans; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytosis; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; T-Lymphocytes, Cytotoxic; Thiazoles; Thrombocytopenia | 2014 |
Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome.
Topics: Acute Disease; Biopsy; Bone Marrow; Chronic Disease; Dasatinib; Humans; Leukemia; Myelodysplastic Syndromes; Pleura; Pleural Effusion; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.
Topics: Clinical Trials as Topic; Contraindications; Dasatinib; Drug Interactions; Gastrointestinal Tract; Heart Diseases; Hematologic Diseases; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pleural Effusion; Pyrimidines; Thiazoles | 2009 |
New approved dasatinib regimen available for clinical use.
Topics: Clinical Trials, Phase III as Topic; Dasatinib; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Chronic-Phase; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Thrombocytopenia | 2009 |
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
Topics: Benzamides; Cell Proliferation; Cytotoxicity, Immunologic; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Activation; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Serositis; Thiazoles; Treatment Outcome | 2009 |
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.
Topics: Algorithms; Dasatinib; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Water-Electrolyte Imbalance | 2009 |
Pleural effusions due to dasatinib.
Topics: Clinical Trials as Topic; Dasatinib; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles | 2010 |
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.
Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Dasatinib; Disease Management; Drug Administration Schedule; Drug Eruptions; Humans; Hypercholesterolemia; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome | 2010 |
Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.
Topics: Antineoplastic Agents; Dasatinib; Drug Administration Schedule; Drug Interactions; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukopenia; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2010 |
5 trial(s) available for thiazoles and Pleural Effusion
Article | Year |
---|---|
Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Dasatinib; Disease Management; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Gastrointestinal Hemorrhage; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Proteins; Piperazines; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; src-Family Kinases; Thiazoles; Young Adult | 2010 |
Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors.
Topics: Aged; Anorexia; Antineoplastic Agents; Biomarkers; Bone Resorption; Dasatinib; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Diseases; Humans; Japan; Magnesium; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Proteins; Neoplasms; Osteoclasts; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; src-Family Kinases; Thiazoles | 2011 |
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dasatinib; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Longitudinal Studies; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Thiazoles; Young Adult | 2011 |
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Cytogenetic Analysis; Dasatinib; Disease-Free Survival; Drug Resistance; Edema; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pancytopenia; Piperazines; Pleural Effusion; Pyrimidines; Salvage Therapy; Thiazoles; Treatment Outcome | 2007 |
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Dasatinib; Drug Administration Schedule; Drug Monitoring; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Multivariate Analysis; Piperazines; Pleural Effusion; Pyrimidines; Radiography; Risk Factors; Thiazoles; Treatment Failure | 2007 |
23 other study(ies) available for thiazoles and Pleural Effusion
Article | Year |
---|---|
Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Aged; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Male; Pleural Effusion; Pyrimidines; Thiazoles | 2021 |
Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
Topics: Acute Kidney Injury; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pleural Effusion; Pyrimidines; Thiazoles | 2014 |
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytosis; Male; Middle Aged; Neoplasm Grading; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Survival Rate; Thiazoles; Treatment Outcome | 2014 |
Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pleural Effusion; Pneumocystis carinii; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Outcome | 2014 |
Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.
Topics: Aged; Dasatinib; Dyspnea; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Tomography, X-Ray Computed | 2015 |
[Guidelines for the management of dasatinib (Sprycel)-induced side effects in chronic myelogenous leukemia and Philadelphia positive acute lymphoblastic leukemias].
Topics: Antineoplastic Agents; Benzamides; Bone Marrow; Bone Marrow Diseases; Dasatinib; Drug Resistance, Neoplasm; Female; France; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Pyrimidines; Thiazoles | 2008 |
Dasatinib-induced pleural effusions: a lymphatic network disorder?
Topics: Adult; Aged; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2009 |
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.
Topics: Adult; Aged; Antineoplastic Agents; Dasatinib; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Chronic-Phase; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles | 2010 |
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase.
Topics: Aged; Antineoplastic Agents; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Substance Withdrawal Syndrome; Thiazoles | 2010 |
The combination of thymosin and methylprednisolone for the treatment of a patient with colonic ulcers, subcutaneous nodules, and pleural effusion after dasatinib treatment for chronic myeloid leukemia.
Topics: Aged; Anti-Inflammatory Agents; Colonic Diseases; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Pleural Effusion; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Subcutaneous Tissue; Thiazoles; Thymosin; Treatment Outcome; Ulcer | 2010 |
[Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colitis; Cytomegalovirus Infections; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Philadelphia Chromosome; Pleural Effusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Thiazoles; Treatment Outcome | 2010 |
Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Dasatinib; Female; Humans; Leukemia, Large Granular Lymphocytic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytes; Lymphocytosis; Male; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2010 |
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily.
Topics: Adult; Aged; Antineoplastic Agents; Dasatinib; Drug Administration Schedule; Female; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome | 2011 |
Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.
Topics: Aged; Dasatinib; Diuretics; Drug Administration Schedule; Female; Furosemide; Glucocorticoids; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Risk Factors; Severity of Illness Index; Thiazoles; Turkey | 2011 |
The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply).
Topics: Dasatinib; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pericardial Effusion; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2011 |
Talc crystals in pleurodesis-associated talc granuloma.
Topics: Aged; Biopsy, Fine-Needle; Cytoplasm; Dasatinib; Giant Cells; Granuloma, Foreign-Body; Humans; Immunohistochemistry; Macrophages; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Pleural Effusion; Pleurodesis; Positron-Emission Tomography; Pyrimidines; Talc; Thiazoles; Tomography, X-Ray Computed | 2012 |
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib.
Topics: Aged; Antineoplastic Agents; Dasatinib; Female; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Medication Adherence; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Thiazoles; Treatment Outcome | 2011 |
Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities.
Topics: Antineoplastic Agents; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Medication Adherence; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2011 |
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
Topics: Aged; Cytogenetics; Dasatinib; Female; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles | 2013 |
Dasatinib-related alveolar pneumonia responsive to corticosteroids.
Topics: Adrenal Cortex Hormones; Dasatinib; Humans; Hydroxyurea; Lung; Male; Middle Aged; Pleural Effusion; Pneumonia; Protein Kinase Inhibitors; Pulmonary Alveoli; Pyrimidines; Remission Induction; Steroids; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Dasatinib in chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Paracentesis; Pleural Effusion; Pleurodesis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2006 |
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Chest Pain; Cough; Dasatinib; Dyspnea; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lymphocytes; Male; Middle Aged; Myeloid Cells; Neutrophils; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Radiography; Thiazoles | 2007 |
Inflammatory effects of acetylglycerylether phosphorylcholine: vascular permeability increase and induction of pleurisy in rats.
Topics: Animals; Azo Compounds; Bradykinin; Capillary Permeability; Dexamethasone; Guinea Pigs; Histamine; Indomethacin; Inflammation; Injections; Leukocyte Count; Male; Methysergide; Phospholipid Ethers; Platelet Activating Factor; Pleural Effusion; Pleurisy; Prostaglandins; Pyrilamine; Rabbits; Rats; Rats, Inbred Strains; Serotonin; Skin; Skin Physiological Phenomena; Thiazoles; Trypan Blue | 1986 |